How AstraZeneca’s latest vaccine troubles could slow the global recovery
3 years, 8 months ago

How AstraZeneca’s latest vaccine troubles could slow the global recovery

CNN  

London CNN Business — AstraZeneca’s vaccine is key to ending the global economic slump caused by the coronavirus. The World Health Organization said in a statement Wednesday that “based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.” AstraZeneca said that nearly 200 million people around the world have already received its vaccine, and that reviews by EU and UK regulators “reaffirmed the vaccine offers a high-level of protection against all severities of Covid-19 and that these benefits continue to far outweigh the risks.” A medical worker prepares to innoculate a woman with a dose of AstraZeneca's vaccine in Hyderabad on Apr. Germany’s vaccine commission said in January that AstraZeneca’s shots shouldn’t be given to people older than 65, citing insufficient data for the age group. The US National Institute of Allergy and Infectious Diseases expressed concerns that the efficacy information submitted was “outdated.” AstraZeneca quickly sent in revised data, but Dr. Anthony Fauci, the agency’s director, called it “an unforced error.” Now, as fears about rare blood clots force governments around the world to reassess the risk-benefit analysis of providing shots to all age groups, the United States has indicated it does not need AstraZeneca’s doses. But coupled with supply shortages, new restrictions could complicate the recovery in countries where AstraZeneca’s vaccine is central to pandemic exit strategies, May said.

Europe Vaccines Countries Cnn European Astrazeneca Lazarus Global Vaccine Its Vaccine  vaccines  slow  astrazeneca  supply  global  vaccine  blood  countries  recovery  shots  data  troubles  astrazenecas  latest

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 2 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
7 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
7 months, 2 weeks ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
7 months, 2 weeks ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

AstraZeneca pulls its COVID-19 vaccine from the European market
7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
7 months, 2 weeks ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
7 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
7 months, 2 weeks ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court
7 months, 3 weeks ago

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court

News 18  

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported. In a legal document submitted to a UK court in February, the Cambridge-based company conceded that …

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research
1 year ago

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research

Firstpost  

Governments, including the EU’s second-most populous country France, have been reluctant to reveal the scale of the waste, but it is certain that most EU nations have resorted to wasting doses of the Covid-19 vaccine, once a much sought after commodity Nearly 215 million doses of Covid-19 vaccines purchased by EU countries at the height of the pandemic have since …

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab
1 year ago

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab

The Telegraph  

Iskra Reic, executive vice president of vaccines and immune therapies at AstraZeneca, said: “This aligns with our strategy to deliver a portfolio of therapies to address high unmet needs in infectious diseases, and our ambition to protect the most vulnerable patients who have high risk of severe outcomes.” Shares in AstraZeneca rose 1.3pc in afternoon trade on news of the …

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know
1 year, 1 month ago

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know

Daily Mail  

As Brits take AstraZeneca to court we recount what happened with the Covid jab AstraZeneca's Covid vaccine undoubtedly saved millions of lives. AstraZeneca's Covid jab timeline January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a 'Public Health Emergency of International Concern' March 2020: Then Prime Minister …

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year
1 year, 10 months ago

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. A year earlier the business sold 1.8 billion US …

Explained | Can vaccine distribution be made fairer?
2 years, 1 month ago

Explained | Can vaccine distribution be made fairer?

The Hindu  

The story so far: The Global Dashboard for Vaccine Equity, a joint effort by the United Nations Development Programme, the World Health Organization and the University of Oxford with cooperation across the UN system, has put out recent data that justifies the vexatious core of the vaccine distribution programme: Only one in four people has been vaccinated with at least …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 1 month ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 1 month ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 7 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

Weighing the choices: on precautionary vaccine doses
2 years, 8 months ago

Weighing the choices: on precautionary vaccine doses

The Hindu  

As India sees a steady slump in its daily coronavirus count, the Centre has announced opening up the third, or ‘precautionary doses’, to everyone over 18 years. A major aspect of vaccines is the risk of adverse events following vaccination, and previous experience has suggested that certain vaccines may induce a higher risk of blood clots in younger populations. With …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

Rich countries getting new Novavax COVID-19 vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new Novavax COVID-19 vaccine before poorer ones

LA Times  

The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the United Nations-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The investment guaranteed COVAX the “right of first refusal” to …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist
2 years, 10 months ago

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} An Oxford …

This is how the COVID-19 health emergency could be over this year, WHO says
2 years, 11 months ago

This is how the COVID-19 health emergency could be over this year, WHO says

LA Times  

John Nkengasong, left, director of the Africa Centers for Disease Control and Prevention, and moderator Julia Chatterley during a remote panel on vaccine equity at the World Economic Forum on Tuesday. Dr. Michael Ryan, speaking during a panel discussion on vaccine inequity hosted by the World Economic Forum, said “we may never end the virus” because such pandemic viruses “end …

Poorer nations reject over 100 million Covid shots as many close to expiry
2 years, 11 months ago

Poorer nations reject over 100 million Covid shots as many close to expiry

India Today  

Poorer nations last month rejected more than 100 million doses of Covid-19 vaccines distributed by the global programme COVAX, mainly due to their rapid expiry date, a UNICEF official said on Thursday. UNICEF's data on supplies and use of delivered vaccines show that 681 million shipped doses are currently stored in about 90 poorer nations, according to CARE, a charity, …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

The world has failed at vaccine equity. Will 2022 be different?
3 years ago

The world has failed at vaccine equity. Will 2022 be different?

Al Jazeera  

On December 4, 2020, a 90-year-old grandmother in the United Kingdom became the first person in the world to receive a vaccine proven to be highly effective against COVID-19, kicking off a rollout of inoculants developed with unprecedented speed under dire circumstances in high-income countries across the globe. “I think that’s unquestionable.” The COVAX scheme initially aimed to achieve a …

WHO: Africa might miss 70% vaccination goal until late 2024
3 years ago

WHO: Africa might miss 70% vaccination goal until late 2024

Associated Press  

NAIROBI, Kenya — The African continent might not reach the target of vaccinating 70% of its 1.3 billion population against COVID-19 until the second half of 2024, a target many of the world’s richer countries have already met, the World Health Organization said Tuesday. Health officials in South Africa, which first announced the variant, say early data indicate it causes …

WHO warns fears of Omicron could spark new vaccine hoarding
3 years ago

WHO warns fears of Omicron could spark new vaccine hoarding

India Today  

The World Health Organisation expressed concerns on Thursday that rich countries spooked by the emergence of the Omicron variant could step up the hoarding of Covid-19 vaccines and strain global supplies again, complicating efforts to stamp out the pandemic. “What is going to shut down disease is for everybody who is especially at risk of disease to become vaccinated,” said …

WHO warns fears of omicron could spark new vaccine hoarding
3 years ago

WHO warns fears of omicron could spark new vaccine hoarding

The Hindu  

The World Health Organization expressed concerns Thursday that rich countries spooked by the emergence of the omicron variant could step up the hoarding of COVID-19 vaccines and strain global supplies again, complicating efforts to stamp out the pandemic. “What is going to shut down disease is for everybody who is especially at risk of disease to become vaccinated,” said Dr. …

WHO warns against rich nations hoarding jabs to fight Omicron
3 years ago

WHO warns against rich nations hoarding jabs to fight Omicron

Al Jazeera  

Key problem for international dose-sharing programme is wealthy countries donating COVID-19 vaccines with short shelf life, WHO says. The World Health Organization official has warned that wealthy countries may start hoarding COVID-19 vaccines again, threatening global supplies as they seek to shore up stocks to fight the new Omicron variant of coronavirus. The comments on Thursday by the agency’s vaccine …

Next pandemic may be worse, says scientist behind UK's Covid-19 vaccine
3 years ago

Next pandemic may be worse, says scientist behind UK's Covid-19 vaccine

India Today  

One of the scientists behind the Oxford-AstraZeneca Covid-19 vaccine is warning that the next pandemic may be more contagious and more lethal unless more money is devoted to research and preparations to fight emerging viral threats. In excerpts released before a speech Monday, Professor Sarah Gilbert says the scientific advances made in fighting deadly viruses “must not be lost” because …

Variants, boosters turn rich-poor vaccine gap into chasm
3 years ago

Variants, boosters turn rich-poor vaccine gap into chasm

Associated Press  

PARIS — The global initiative to share coronavirus vaccines fairly already scaled back its pledge to the world’s poor once. Now, to meet even that limited promise, COVAX would have to deliver more than a million doses every hour until the end of the year in some of the world’s most challenging places. COVAX’s new promise is for 1.4 billion …

December 2, 2021 Omicron coronavirus variant news
3 years ago

December 2, 2021 Omicron coronavirus variant news

CNN  

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe on Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Massachusetts. Any one of six different Covid-19 vaccines produce a strong immune system response and should work safely and well as boosters for people who have received initial vaccinations with either the Pfizer/BioNTech or AstraZeneca vaccines, British researchers …

December 2, 2021 Omicron coronavirus variant news
3 years ago

December 2, 2021 Omicron coronavirus variant news

CNN  

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe on Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Massachusetts. Any one of six different Covid-19 vaccines produce a strong immune system response and should work safely and well as boosters for people who have received initial vaccinations with either the Pfizer/BioNTech or AstraZeneca vaccines, British researchers …

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm
3 years, 1 month ago

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm

The Telegraph  

It is the key question puzzling scientists and commentators – how is Britain managing to weather the latest deadly Covid storm while our European neighbours' defences are crumbling? He suggested that the durability of T-cells from the Oxford/AstraZeneca jab could be keeping older people safer than those on the continent, preventing hospitilisations and deaths even though virus cases are still …

AstraZeneca age group has fewer antibodies against corona, blood bank finds
3 years, 1 month ago

AstraZeneca age group has fewer antibodies against corona, blood bank finds

Dutch News  

People in their early sixties, the age group that was given the AstraZeneca vaccine, have fewer antibodies against coronavirus than other vaccinated groups, according to national blood bank Sanquin. A study of around 1,400 samples from blood donors found that people in the 18 to 25 age group had on average eight times as many antibodies as people aged 61 …

Mix-and-match vaccines highly effective against COVID-19: Lancet study
3 years, 2 months ago

Mix-and-match vaccines highly effective against COVID-19: Lancet study

Deccan Chronicle  

London: People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden. "However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received …

Australia plans to stop AstraZeneca vaccine production — but how will it affect our neighbours?
3 years, 2 months ago

Australia plans to stop AstraZeneca vaccine production — but how will it affect our neighbours?

ABC  

The federal opposition and aid groups are urging the government to extend its contract with biotech giant CSL to manufacture more AstraZeneca vaccines in Melbourne, saying Australia should ramp up production next year to help vanquish the COVID-19 pandemic. Key points: Around 12.5 million AstraZeneca doses have been administered to Australians, while more than 3.5 million doses have been sent …

AstraZeneca asks FDA to authorise COVID antibody treatment
3 years, 2 months ago

AstraZeneca asks FDA to authorise COVID antibody treatment

The Hindu  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 2 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

AstraZeneca picks up new vaccine technology originally intended to target Covid
3 years, 3 months ago

AstraZeneca picks up new vaccine technology originally intended to target Covid

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Scientists at Imperial College London are partnering with AstraZeneca to develop …

WHO aims for 30 percent of needed Africa COVID jabs by February
3 years, 3 months ago

WHO aims for 30 percent of needed Africa COVID jabs by February

Al Jazeera  

The WHO and its partners hope to provide Africa with about 30 percent of vaccines by February. The World Health Organization and its partners have said they hope to provide Africa with about 30 percent of the COVID-19 vaccines the continent needs by February, badly missing the 60 percent vaccination coverage goal that African leaders had once hoped for this …

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
3 years, 3 months ago

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary

Firstpost  

Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant London: Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor Sarah Gilbert told The Telegraph newspaper that …

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa
3 years, 3 months ago

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa

Live Mint  

The European Union will return to Africa millions of doses of Johnson & Johnson’s Covid-19 vaccine that it received from a plant in South Africa, following criticism by health activists that the bloc was taking away shots from a continent that has the lowest immunization rate in the world. Strive Masiyiwa, who heads the African Union’s Vaccine Acquisition Task Team, …

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting
3 years, 3 months ago

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting

ABC  

The nation's peak medical body has issued a stark warning: if you're over 60 and are hoping to get the Pfizer COVID-19 jab, you could die waiting. Key points: More than half a million Australians aged between 60 and 69 haven't received a single COVID-19 vaccine dose The Prime Minister has penned a letter urging Australians over 60 to get …

Leftover AstraZeneca vaccines discarded despite hopes they will be donated
3 years, 4 months ago

Leftover AstraZeneca vaccines discarded despite hopes they will be donated

NL Times  

Tens of thousands of leftover AstraZeneca Covid-19 vaccines will soon end up in the trash. “You are not sure if the vaccines were always stored at the right temperature and if they still work optimally”, the spokesperson of the Ministry of Health said. AstraZeneca vaccines must be stored at between two to eight degrees Celsius, otherwise, they become less effective. …

What is being done to distribute COVID-19 vaccines globally?
3 years, 4 months ago

What is being done to distribute COVID-19 vaccines globally?

Associated Press  

LONDON — What is being done to distribute COVID-19 vaccines globally? Several groups are working to get shots to poor countries, but they’re falling far short of what’s needed to curb outbreaks around the world. Without enough purchased vaccines, COVAX is now relying on donated shots from wealthy countries, but most of the pledged doses won’t be delivered this year. …

COVID vaccine efficacy wanes, but jabs offer protection: Study
3 years, 4 months ago

COVID vaccine efficacy wanes, but jabs offer protection: Study

Al Jazeera  

Oxford University researchers say efficacy of Pfizer, AstraZeneca weakens 90 days after second dose, but both ‘still doing really well against Delta’ strain. The efficacy of two widely used coronavirus vaccines against the Delta variant weakens within three months of inoculation, but the jabs remain the most effective way to ensure protection against the strain, Oxford University researchers have found. …

Discover Related